210 related articles for article (PubMed ID: 30849179)
1. Protein inhibitor of activated STAT1 Ser
Liu SY; Ma YL; Hsu WL; Chiou HY; Lee EHY
Br J Pharmacol; 2019 Jun; 176(11):1793-1810. PubMed ID: 30849179
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of HDAC1 SUMOylation as an endogenous neuroprotection against Aβ toxicity in a mouse model of Alzheimer's disease.
Tao CC; Hsu WL; Ma YL; Cheng SJ; Lee EH
Cell Death Differ; 2017 Apr; 24(4):597-614. PubMed ID: 28186506
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
[TBL] [Abstract][Full Text] [Related]
4. CREB SUMOylation by the E3 ligase PIAS1 enhances spatial memory.
Chen YC; Hsu WL; Ma YL; Tai DJ; Lee EH
J Neurosci; 2014 Jul; 34(29):9574-89. PubMed ID: 25031400
[TBL] [Abstract][Full Text] [Related]
5. Melatonin Induction of APP Intracellular Domain 50 SUMOylation Alleviates AD through Enhanced Transcriptional Activation and Aβ Degradation.
Liu YC; Hsu WL; Ma YL; Lee EHY
Mol Ther; 2021 Jan; 29(1):376-395. PubMed ID: 32950104
[TBL] [Abstract][Full Text] [Related]
6. Functional genomics study of protein inhibitor of activated STAT1 in mouse hippocampal neuronal cells revealed by RNA sequencing.
He K; Zhang J; Liu J; Cui Y; Liu LG; Ye S; Ban Q; Pan R; Liu D
Aging (Albany NY); 2021 Mar; 13(6):9011-9027. PubMed ID: 33759814
[TBL] [Abstract][Full Text] [Related]
7. p38 MAPK pathway-dependent SUMOylation of Elk-1 and phosphorylation of PIAS2 correlate with the downregulation of Elk-1 activity in heat-stressed HeLa cells.
Chowdhury D; Singh A; Gupta A; Tulsawani R; Meena RC; Chakrabarti A
Cell Stress Chaperones; 2019 Mar; 24(2):393-407. PubMed ID: 30783905
[TBL] [Abstract][Full Text] [Related]
8. Hes-1 SUMOylation by protein inhibitor of activated STAT1 enhances the suppressing effect of Hes-1 on GADD45α expression to increase cell survival.
Chiou HY; Liu SY; Lin CH; Lee EH
J Biomed Sci; 2014 Jun; 21(1):53. PubMed ID: 24894488
[TBL] [Abstract][Full Text] [Related]
9. Effects of aerobic exercise on hippocampal SUMOylation in APP/PS1 transgenic mice.
Chenfei Z; Haizhen Y; Jie X; Na Z; Bo X
Neurosci Lett; 2022 Jan; 767():136303. PubMed ID: 34695453
[TBL] [Abstract][Full Text] [Related]
10. SUMO E3 ligase PIAS1 is a potential biomarker indicating stress susceptibility.
Lin HY; Liu YS; Huang CY; Cathomas F; Liu K; Wang J; Cheng HT; Lai SW; Liu YC; Chen CJ; Lin C; Lu DY
Psychoneuroendocrinology; 2020 Oct; 120():104800. PubMed ID: 32688147
[TBL] [Abstract][Full Text] [Related]
11. Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.
Gur I; Fujiwara K; Hasegawa K; Yoshikawa K
PLoS One; 2014; 9(6):e99503. PubMed ID: 24911587
[TBL] [Abstract][Full Text] [Related]
12. Novel role and mechanism of protein inhibitor of activated STAT1 in spatial learning.
Tai DJ; Hsu WL; Liu YC; Ma YL; Lee EH
EMBO J; 2011 Jan; 30(1):205-20. PubMed ID: 21102409
[TBL] [Abstract][Full Text] [Related]
13. PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation.
Xie B; Liu X; Yang J; Cheng J; Gu J; Xue S
BMC Cell Biol; 2018 Nov; 19(1):24. PubMed ID: 30419807
[TBL] [Abstract][Full Text] [Related]
14. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
[TBL] [Abstract][Full Text] [Related]
15. Neuronal activity-induced SUMOylation of Akt1 by PIAS3 is required for long-term potentiation of synaptic transmission.
Meng L; Du CP; Lu CY; Zhang K; Li L; Yan JZ; Hou XY
FASEB J; 2021 Aug; 35(8):e21769. PubMed ID: 34288124
[TBL] [Abstract][Full Text] [Related]
16. Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis.
Liu Y; Zhang YD; Guo L; Huang HY; Zhu H; Huang JX; Liu Y; Zhou SR; Dang YJ; Li X; Tang QQ
Mol Cell Biol; 2013 Nov; 33(22):4606-17. PubMed ID: 24061474
[TBL] [Abstract][Full Text] [Related]
17. Leukemogenic kinase FIP1L1-PDGFRA and a small ubiquitin-like modifier E3 ligase, PIAS1, form a positive cross-talk through their enzymatic activities.
Ibata M; Iwasaki J; Fujioka Y; Nakagawa K; Darmanin S; Onozawa M; Hashimoto D; Ohba Y; Hatakeyama S; Teshima T; Kondo T
Cancer Sci; 2017 Feb; 108(2):200-207. PubMed ID: 27960034
[TBL] [Abstract][Full Text] [Related]
18. High mobility group nucleosomal binding domain 2 (HMGN2) SUMOylation by the SUMO E3 ligase PIAS1 decreases the binding affinity to nucleosome core particles.
Wu J; Kim S; Kwak MS; Jeong JB; Min HJ; Yoon HG; Ahn JH; Shin JS
J Biol Chem; 2014 Jul; 289(29):20000-11. PubMed ID: 24872413
[TBL] [Abstract][Full Text] [Related]
19. A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors.
Zhang Y; Gan Z; Huang P; Zhou L; Mao T; Shao M; Jiang X; Chen Y; Ying H; Cao M; Li J; Li J; Zhang WJ; Yang L; Liu Y
J Biol Chem; 2012 Nov; 287(45):37973-85. PubMed ID: 22969086
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
